NO802014L - Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-pyridinderivater - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-pyridinderivaterInfo
- Publication number
- NO802014L NO802014L NO802014A NO802014A NO802014L NO 802014 L NO802014 L NO 802014L NO 802014 A NO802014 A NO 802014A NO 802014 A NO802014 A NO 802014A NO 802014 L NO802014 L NO 802014L
- Authority
- NO
- Norway
- Prior art keywords
- methyl
- pyridine
- pyrrolo
- bromine
- tetrahydro
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 10
- 238000002360 preparation method Methods 0.000 title claims description 4
- 150000005255 pyrrolopyridines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 23
- 239000001257 hydrogen Substances 0.000 claims description 16
- 229910052739 hydrogen Inorganic materials 0.000 claims description 16
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 15
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 12
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 10
- 229910052794 bromium Inorganic materials 0.000 claims description 10
- 150000002431 hydrogen Chemical group 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 7
- 239000007858 starting material Substances 0.000 claims description 7
- 150000001412 amines Chemical class 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 239000000460 chlorine Substances 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- 239000007795 chemical reaction product Substances 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- -1 pyrrolidino-methyl Chemical group 0.000 claims description 4
- WIBUSVGJVAYNBU-UHFFFAOYSA-N 4-(4-bromophenyl)-1,6-dimethyl-5,7-dihydro-4h-pyrrolo[2,3-c]pyridine Chemical compound C1=2C=CN(C)C=2CN(C)CC1C1=CC=C(Br)C=C1 WIBUSVGJVAYNBU-UHFFFAOYSA-N 0.000 claims description 3
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 3
- 229920002866 paraformaldehyde Polymers 0.000 claims description 3
- YYLVBYQDRJYOTK-UHFFFAOYSA-N 4-phenyl-4,5,6,7-tetrahydro-1h-pyrrolo[2,3-c]pyridine Chemical class C1NCC=2NC=CC=2C1C1=CC=CC=C1 YYLVBYQDRJYOTK-UHFFFAOYSA-N 0.000 claims description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- 238000006683 Mannich reaction Methods 0.000 claims description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 2
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 2
- 239000011737 fluorine Chemical group 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 125000005842 heteroatom Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 5
- CWLOFLFPSNCBFN-UHFFFAOYSA-N 2-bromo-4-(4-bromophenyl)-1,6-dimethyl-5,7-dihydro-4h-pyrrolo[2,3-c]pyridine Chemical compound C1=2C=C(Br)N(C)C=2CN(C)CC1C1=CC=C(Br)C=C1 CWLOFLFPSNCBFN-UHFFFAOYSA-N 0.000 claims 1
- GYNPKCPHHBWISN-UHFFFAOYSA-N 4-(4-bromophenyl)-1,3,6-trimethyl-2-piperidin-1-yl-5,7-dihydro-4H-pyrrolo[2,3-c]pyridine Chemical compound CN1C(=C(C2=C1CN(CC2C2=CC=C(C=C2)Br)C)C)N2CCCCC2 GYNPKCPHHBWISN-UHFFFAOYSA-N 0.000 claims 1
- LNVJOEISRQDAHH-UHFFFAOYSA-N 4-(4-bromophenyl)-1,3,6-trimethyl-2-pyrrolidin-1-yl-5,7-dihydro-4H-pyrrolo[2,3-c]pyridine Chemical compound CN1C(=C(C2=C1CN(CC2C2=CC=C(C=C2)Br)C)C)N2CCCC2 LNVJOEISRQDAHH-UHFFFAOYSA-N 0.000 claims 1
- HQVOLDSMHIXLGI-UHFFFAOYSA-N 4-(4-bromophenyl)-1-methyl-4,5,6,7-tetrahydropyrrolo[2,3-c]pyridine Chemical compound C1NCC=2N(C)C=CC=2C1C1=CC=C(Br)C=C1 HQVOLDSMHIXLGI-UHFFFAOYSA-N 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 6
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 4
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 4
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- QEVHRUUCFGRFIF-MDEJGZGSSA-N reserpine Chemical group O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 QEVHRUUCFGRFIF-MDEJGZGSSA-N 0.000 description 4
- 229960003147 reserpine Drugs 0.000 description 4
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229960002748 norepinephrine Drugs 0.000 description 3
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 3
- 229920000137 polyphosphoric acid Polymers 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000007363 ring formation reaction Methods 0.000 description 3
- 229940076279 serotonin Drugs 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000001430 anti-depressive effect Effects 0.000 description 2
- 239000000935 antidepressant agent Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000000035 biogenic effect Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- ULSIYEODSMZIPX-UHFFFAOYSA-N phenylethanolamine Chemical compound NCC(O)C1=CC=CC=C1 ULSIYEODSMZIPX-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 210000003568 synaptosome Anatomy 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NFLPHHPXDZQSTM-BTJKTKAUSA-N (z)-but-2-enedioic acid;1,6-dimethyl-4-phenyl-5,7-dihydro-4h-pyrrolo[2,3-c]pyridine Chemical compound OC(=O)\C=C/C(O)=O.C1=2C=CN(C)C=2CN(C)CC1C1=CC=CC=C1 NFLPHHPXDZQSTM-BTJKTKAUSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- DYGBNRBUPVOQEQ-UHFFFAOYSA-N 1,6-dimethyl-4-(4-methylphenyl)-5,7-dihydro-4h-pyrrolo[2,3-c]pyridine Chemical compound C1=2C=CN(C)C=2CN(C)CC1C1=CC=C(C)C=C1 DYGBNRBUPVOQEQ-UHFFFAOYSA-N 0.000 description 1
- YYKZOPHCAIUFOX-UHFFFAOYSA-N 1,6-dimethyl-4-phenyl-5,7-dihydro-4h-pyrrolo[2,3-c]pyridine Chemical compound C1=2C=CN(C)C=2CN(C)CC1C1=CC=CC=C1 YYKZOPHCAIUFOX-UHFFFAOYSA-N 0.000 description 1
- OXHNLMTVIGZXSG-UHFFFAOYSA-N 1-Methylpyrrole Chemical class CN1C=CC=C1 OXHNLMTVIGZXSG-UHFFFAOYSA-N 0.000 description 1
- JEIXBDVROOEFBU-UHFFFAOYSA-N 1-[4-(4-bromophenyl)-1,6-dimethyl-5,7-dihydro-4h-pyrrolo[2,3-c]pyridin-2-yl]-n,n-dimethylmethanamine Chemical compound C1N(C)CC=2N(C)C(CN(C)C)=CC=2C1C1=CC=C(Br)C=C1 JEIXBDVROOEFBU-UHFFFAOYSA-N 0.000 description 1
- VWVNUJVXMUMFLI-UHFFFAOYSA-N 1-methyl-4-(4-methylphenyl)-4,5,6,7-tetrahydropyrrolo[2,3-c]pyridine Chemical compound C1=CC(C)=CC=C1C1C(C=CN2C)=C2CNC1 VWVNUJVXMUMFLI-UHFFFAOYSA-N 0.000 description 1
- NNINSLOEPXEZOZ-UHFFFAOYSA-N 2-(4-bromophenyl)oxirane Chemical compound C1=CC(Br)=CC=C1C1OC1 NNINSLOEPXEZOZ-UHFFFAOYSA-N 0.000 description 1
- GIVXVDYWAGCDPZ-UHFFFAOYSA-N 2-tert-butyl-4-(4-chlorophenyl)-1,6-dimethyl-5,7-dihydro-4h-pyrrolo[2,3-c]pyridine Chemical compound C1=2C=C(C(C)(C)C)N(C)C=2CN(C)CC1C1=CC=C(Cl)C=C1 GIVXVDYWAGCDPZ-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- SGYUYMCIKHNIHS-UHFFFAOYSA-N 4-(4-bromophenyl)-1,6-dimethyl-2-(piperidin-1-ylmethyl)-5,7-dihydro-4h-pyrrolo[2,3-c]pyridine Chemical compound CN1C=2CN(C)CC(C=3C=CC(Br)=CC=3)C=2C=C1CN1CCCCC1 SGYUYMCIKHNIHS-UHFFFAOYSA-N 0.000 description 1
- JHMIYSCBAVTASX-UHFFFAOYSA-N 4-(4-bromophenyl)-1,6-dimethyl-2-(pyrrolidin-1-ylmethyl)-5,7-dihydro-4h-pyrrolo[2,3-c]pyridine Chemical compound CN1C=2CN(C)CC(C=3C=CC(Br)=CC=3)C=2C=C1CN1CCCC1 JHMIYSCBAVTASX-UHFFFAOYSA-N 0.000 description 1
- YIUDPPDXQQXWKX-UHFFFAOYSA-N 4-(4-bromophenyl)-2,6-dimethyl-1,4,5,7-tetrahydropyrrolo[2,3-c]pyridine Chemical compound C1=2C=C(C)NC=2CN(C)CC1C1=CC=C(Br)C=C1 YIUDPPDXQQXWKX-UHFFFAOYSA-N 0.000 description 1
- SVDDXDJAKBJZFY-UHFFFAOYSA-N 4-(4-chlorophenyl)-1,6-dimethyl-5,7-dihydro-4h-pyrrolo[2,3-c]pyridine Chemical compound C1=2C=CN(C)C=2CN(C)CC1C1=CC=C(Cl)C=C1 SVDDXDJAKBJZFY-UHFFFAOYSA-N 0.000 description 1
- FTJJWXQQAXEVOB-UHFFFAOYSA-N 4-(4-fluorophenyl)-1,6-dimethyl-5,7-dihydro-4h-pyrrolo[2,3-c]pyridine Chemical compound C1=2C=CN(C)C=2CN(C)CC1C1=CC=C(F)C=C1 FTJJWXQQAXEVOB-UHFFFAOYSA-N 0.000 description 1
- SXWMYJAHZMCABA-UHFFFAOYSA-N 4-(4-methoxyphenyl)-1,6-dimethyl-5,7-dihydro-4h-pyrrolo[2,3-c]pyridine Chemical compound C1=CC(OC)=CC=C1C1C(C=CN2C)=C2CN(C)C1 SXWMYJAHZMCABA-UHFFFAOYSA-N 0.000 description 1
- IPIUZDBKNJESNW-UHFFFAOYSA-N 4-[(1,6-dimethyl-4-phenyl-5,7-dihydro-4h-pyrrolo[2,3-c]pyridin-2-yl)methyl]morpholine Chemical compound CN1C=2CN(C)CC(C=3C=CC=CC=3)C=2C=C1CN1CCOCC1 IPIUZDBKNJESNW-UHFFFAOYSA-N 0.000 description 1
- CUYMQVLZFABLGW-UHFFFAOYSA-N 4-[[4-(4-bromophenyl)-1,6-dimethyl-5,7-dihydro-4h-pyrrolo[2,3-c]pyridin-2-yl]methyl]morpholine Chemical compound CN1C=2CN(C)CC(C=3C=CC(Br)=CC=3)C=2C=C1CN1CCOCC1 CUYMQVLZFABLGW-UHFFFAOYSA-N 0.000 description 1
- JMKMDFLQGKTVMY-UHFFFAOYSA-N 6-ethyl-1-methyl-4-(4-methylphenyl)-5,7-dihydro-4h-pyrrolo[2,3-c]pyridine Chemical compound C1=2C=CN(C)C=2CN(CC)CC1C1=CC=C(C)C=C1 JMKMDFLQGKTVMY-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- ZFKXZALCMBWUCH-UHFFFAOYSA-N N-[[4-(4-bromophenyl)-1,6-dimethyl-5,7-dihydro-4H-pyrrolo[2,3-c]pyridin-2-yl]methyl]-N-ethylethanamine Chemical compound C1N(C)CC=2N(C)C(CN(CC)CC)=CC=2C1C1=CC=C(Br)C=C1 ZFKXZALCMBWUCH-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- IQYABPVWEDBKPI-UHFFFAOYSA-N [4-(4-chlorophenyl)-1,6-dimethyl-5,7-dihydro-4h-pyrrolo[2,3-c]pyridin-2-yl]methanol Chemical compound C1=2C=C(CO)N(C)C=2CN(C)CC1C1=CC=C(Cl)C=C1 IQYABPVWEDBKPI-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 150000008050 dialkyl sulfates Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 150000002871 norepinephrines Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229950006768 phenylethanolamine Drugs 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical compound NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 230000001519 thymoleptic effect Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19792927294 DE2927294A1 (de) | 1979-07-06 | 1979-07-06 | Neue 4-phenyl-4,5,6,7-tetrahydropyrrolo eckige klammer auf 2,3-c eckige klammer zu pyridine, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO802014L true NO802014L (no) | 1981-01-07 |
Family
ID=6075042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO802014A NO802014L (no) | 1979-07-06 | 1980-07-04 | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-pyridinderivater |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4315938A (de) |
| JP (1) | JPS5610184A (de) |
| AT (1) | AT375077B (de) |
| AU (1) | AU536336B2 (de) |
| BE (1) | BE884193A (de) |
| CA (1) | CA1138864A (de) |
| CH (1) | CH649548A5 (de) |
| DE (1) | DE2927294A1 (de) |
| DK (1) | DK290380A (de) |
| ES (1) | ES8201019A1 (de) |
| FI (1) | FI802148A (de) |
| FR (1) | FR2460950A1 (de) |
| GB (1) | GB2054580B (de) |
| GR (1) | GR69327B (de) |
| HU (1) | HU182152B (de) |
| IL (1) | IL60499A (de) |
| IT (1) | IT1150024B (de) |
| LU (1) | LU82582A1 (de) |
| NL (1) | NL8003879A (de) |
| NO (1) | NO802014L (de) |
| NZ (1) | NZ194245A (de) |
| PH (1) | PH15756A (de) |
| PT (1) | PT71500B (de) |
| SE (1) | SE436747B (de) |
| YU (1) | YU174780A (de) |
| ZA (1) | ZA804031B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5890951A (ja) * | 1981-11-26 | 1983-05-30 | 住友金属工業株式会社 | 耐食性にすぐれた積層板 |
| JPS59193175A (ja) * | 1983-04-19 | 1984-11-01 | Toa Nenryo Kogyo Kk | 積層物 |
| US4572911A (en) * | 1984-08-02 | 1986-02-25 | Mcneilab, Inc. | Hexahydroindolinzine compounds, pharmaceutical compositions and methods and intermediates |
| WO2021021953A2 (en) * | 2019-07-30 | 2021-02-04 | Sanford Burnham Prebys Medical Discovery Institute | Dopamine receptor d1 agonists and methods of use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1484140A (en) * | 1974-04-24 | 1977-08-24 | Wyeth John & Brother Ltd | Pyrrolopyridine derivatives |
| AT368504B (de) * | 1977-10-15 | 1982-10-25 | Boehringer Sohn Ingelheim | Verfahren zur herstellung neuer 4-phenyl-thieno- (2,3-c)-piperidine |
-
1979
- 1979-07-06 DE DE19792927294 patent/DE2927294A1/de not_active Withdrawn
-
1980
- 1980-06-30 IT IT23120/80A patent/IT1150024B/it active
- 1980-06-30 US US06/163,969 patent/US4315938A/en not_active Expired - Lifetime
- 1980-07-02 AT AT0344680A patent/AT375077B/de not_active IP Right Cessation
- 1980-07-03 GR GR62353A patent/GR69327B/el unknown
- 1980-07-03 CH CH5125/80A patent/CH649548A5/de not_active IP Right Cessation
- 1980-07-03 YU YU01747/80A patent/YU174780A/xx unknown
- 1980-07-04 FR FR8015010A patent/FR2460950A1/fr active Granted
- 1980-07-04 PT PT71500A patent/PT71500B/de unknown
- 1980-07-04 GB GB8022046A patent/GB2054580B/en not_active Expired
- 1980-07-04 NL NL8003879A patent/NL8003879A/nl not_active Application Discontinuation
- 1980-07-04 JP JP9161580A patent/JPS5610184A/ja active Pending
- 1980-07-04 IL IL60499A patent/IL60499A/xx unknown
- 1980-07-04 HU HU801678A patent/HU182152B/hu unknown
- 1980-07-04 AU AU60138/80A patent/AU536336B2/en not_active Ceased
- 1980-07-04 NZ NZ194245A patent/NZ194245A/en unknown
- 1980-07-04 ES ES493104A patent/ES8201019A1/es not_active Expired
- 1980-07-04 ZA ZA00804031A patent/ZA804031B/xx unknown
- 1980-07-04 NO NO802014A patent/NO802014L/no unknown
- 1980-07-04 CA CA000355540A patent/CA1138864A/en not_active Expired
- 1980-07-04 SE SE8004976A patent/SE436747B/sv unknown
- 1980-07-04 LU LU82582A patent/LU82582A1/de unknown
- 1980-07-04 DK DK290380A patent/DK290380A/da not_active Application Discontinuation
- 1980-07-04 FI FI802148A patent/FI802148A/fi not_active Application Discontinuation
- 1980-07-04 BE BE0/201313A patent/BE884193A/fr not_active IP Right Cessation
- 1980-07-07 PH PH24246A patent/PH15756A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB2054580B (en) | 1983-04-07 |
| US4315938A (en) | 1982-02-16 |
| CH649548A5 (de) | 1985-05-31 |
| IL60499A0 (en) | 1980-09-16 |
| LU82582A1 (de) | 1981-09-10 |
| FI802148A (fi) | 1981-01-07 |
| HU182152B (en) | 1983-12-28 |
| FR2460950B1 (de) | 1983-06-24 |
| FR2460950A1 (fr) | 1981-01-30 |
| YU174780A (en) | 1983-02-28 |
| AU536336B2 (en) | 1984-05-03 |
| SE8004976L (sv) | 1981-01-07 |
| ZA804031B (en) | 1982-03-31 |
| AU6013880A (en) | 1981-01-15 |
| CA1138864A (en) | 1983-01-04 |
| AT375077B (de) | 1984-06-25 |
| GR69327B (de) | 1982-05-17 |
| JPS5610184A (en) | 1981-02-02 |
| PH15756A (en) | 1983-03-18 |
| PT71500B (de) | 1981-12-11 |
| IT8023120A0 (it) | 1980-06-30 |
| NZ194245A (en) | 1984-07-06 |
| BE884193A (fr) | 1981-01-05 |
| SE436747B (sv) | 1985-01-21 |
| PT71500A (de) | 1980-08-01 |
| ES493104A0 (es) | 1981-11-01 |
| IL60499A (en) | 1984-02-29 |
| ATA344680A (de) | 1983-11-15 |
| DE2927294A1 (de) | 1981-01-08 |
| IT1150024B (it) | 1986-12-10 |
| GB2054580A (en) | 1981-02-18 |
| DK290380A (da) | 1981-01-07 |
| NL8003879A (nl) | 1981-01-08 |
| ES8201019A1 (es) | 1981-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4065563A (en) | 3-Hetero-5-isothiocyanophenyl oxadiazoles as antifungal and antibacterial agents | |
| Baldwin et al. | Heterocyclic analogs of the antihypertensive. beta.-adrenergic blocking agent (S)-2-[3-(tert-butylamino)-2-hydroxypropoxy]-3-cyanopyridine | |
| IE55156B1 (en) | Pharmacologically active pyrazolo(4,3-c)pyridines | |
| JP2005518357A (ja) | ベータ３アドレナリンアゴニスト | |
| EP0167901B1 (de) | Aktive Verbindungen | |
| NO802014L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-pyridinderivater | |
| NZ202015A (en) | 2-phenyl-2-(pyridyloxy,thio or amino-ethylamine derivatives and pharmaceutical compositions) | |
| US4128666A (en) | 4 AND 5-Halo substituted 2-indanamine compounds | |
| US4297490A (en) | Bicyclic heterocyclic amino derivatives | |
| US4550106A (en) | 4-Phenyl-4,5,6,7-tetrahydro-thieno[2,3-c]pyridines and salts thereof, compositions and use | |
| KR900004694B1 (ko) | 신규 α-아릴-α-피리딜 알카노인산 유도체의 제조방법 | |
| US3345376A (en) | Polyhydro-6-methoxy-1-(3, 4, 5-trimethoxyphenyl)-9h-pyrido[3, 4-b]indoles | |
| KR840001823B1 (ko) | 4-페닐-4, 5, 6, 7-테트라하이드로-피롤로[2, 3-c]-피리딘의 제조방법 | |
| US4987137A (en) | Certain 6,7,8,9-tetrahydropyrido[1,2-α]indoles and their use for the treatment of cerebrovascular disorders | |
| ES2248230T3 (es) | Piperazinilcarbonil-quinolinas e isoquinolinas. | |
| AU747543B2 (en) | Process for converting propargylic amine-N-oxides to enaminones | |
| KR20020058020A (ko) | 술포닐 옥사졸 아민 및 ５-ｈｔ６ 수용체 리간드로서의이의 용도 | |
| US3904614A (en) | Aryl heterocyclic tetrazines and method of preparation thereof | |
| NO143534B (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av oxatiino(1,4)(2,3-c)pyrrol | |
| Kozlowski et al. | Phenylation of the 5, 11‐diazaditwistane nucleus | |
| DK143027B (da) | Analogifremgangsmaade til fremstilling af isoxazolderivater | |
| NO832056L (no) | Fremgangsmaate for fremstilling av aminobenzamidderivater | |
| NO743161L (de) | ||
| NO168895B (no) | Polymert produkt, samt fremgangsmaate for fremstilling derav. | |
| KR20010072407A (ko) | Ｎ-치환 아자비시클로헵탄 유도체, 그의 제조 및 용도 |